JW (Cayman) Therapeutics Co. Ltd (JWCTF)
OTCMKTS
· Delayed Price · Currency is USD
0.1620
0.00 (0.00%)
Apr 30, 2025, 4:00 PM EDT
JWCTF Revenue
In the year 2024, JW (Cayman) Therapeutics Co. had annual revenue of 158.22M CNY, down -8.99%. JW (Cayman) Therapeutics Co. had revenue of 71.40M in the half year ending December 31, 2024, a decrease of -10.40%.
Revenue
158.22M CNY
Revenue Growth
-8.99%
P/S Ratio
3.69
Revenue / Employee
563.05K CNY
Employees
281
Market Cap
79.96M USD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |